Bovilis IBR marker live - Data sheet
Bovilis IBR marker live
Description
Bovilis IBR marker is a live attenuated marker vaccine containing per dose at least 5.7 log10 TCID50 of gE- BoHV-1 strain GK/D.
Indication
Bovine herpesvirus type 1 (BoHV-1) the causative agent of infectious bovine rhinotracheitis (IBR). Bovilis IBR marker is for active immunisation of cattle to reduce the intensity and duration of the clinical signs induced by an infection with BoHV-1 and to reduce excretion of field virus.
Dosage and administration
For intranasal and intramuscular administration. The use of a nozzle is recommended for intranasal administration.
Reconstitute the vaccine immediately before use with Unisolve (2 ml per dose).
Method of administration:
- before the age of 3 months: intranasal
- from the age of 3 months onwards: intranasal or intramuscular
Vaccination schedule
- Basic vaccination:
- Before the age of 3 months:
Two vaccinations, each with a single dose: the first vaccination from the age of 2 weeks onwards and the second vaccination at the age of 3 - 4 months. - From the age of 3 months onwards:
Single vaccination, with one dose per animal
- Before the age of 3 months:
- Revaccination:
- Revaccinate with a single dose every 6 months.
Side effects
After vaccination a slight transient rise in temperature (1°C) can be seen. An increase of nasal discharge can be observed after intranasal vaccination.
Withdrawal period
None
Notes
The vaccine does not elicit antibodies to glycoprotein E of BoHV-1 (marker vaccine). This enables discrimination between cattle vaccinated with the product and cattle infected with BoHV-1 field virus.
Additional information
Use before expiry date printed on the pack.
Storage
Store dark at 2-8°C.
Presentation
Cardboard boxes with 1 or 10 vials, with 5, 10, 25, or 50 doses per vial.